Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

News > East/South/London

Find below news from East of England, South West of England, South East of England and Greater London. Listed are news about these regions as well as from organisations located there.

Total search results: 1932 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AstraZeneca plc. (3/14/19). "Press Release: AstraZeneca Showcases Next-generation Oncology Pipeline Addressing Unmet Patient Needs at AACR Annual Meeting". 2019-03-14
Seres Therapeutics, Inc.. (3/11/19). "Press Release: Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca". Cambridge, MA. 2019-03-11
MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg. 2019-03-07
Nightstar Therapeutics plc. (3/4/19). "Press Release: Nightstar Therapeutics plc Reaches Agreement to Be Acquired by Biogen". 2019-03-04
CN Bio Innovations Ltd.. (2/27/19). "Press Release: CN Bio to Put Ten Organs on “Body-on-a-Chip”". London. 2019-02-27
MeiraGTx Holdings plc. (2/27/19). "Press Release: MeiraGTx Announces $80 Million Private Placement of Ordinary Shares". London & New York, NY. 2019-02-27
Syncona Ltd.. (2/26/19). "Press Release: Syncona Leads CHF 35 Million Series A Financing in Anaveon, a New Immuno-oncology Company". 2019-02-26
Orchard Therapeutics Ltd.. (2/25/19). "Press Release: Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD". Boston, MA & London. 2019-02-25
Boehringer Ingelheim. (2/25/19). "Press Release: New Chief Medical Officer Appointed". Ingelheim. 2019-02-25
Orchard Therapeutics Ltd.. (2/22/19). "Press Release: Orchard Therapeutics Presents Two-year Follow-up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID". Boston, MA & London. 2019-02-22
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
UCB S.A.. (2/15/19). "Press Release: UCB Builds on Its R&D Footprint to Form a Research Satellite Facility within King’s College London". Brussels & Slough. 2019-02-15
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. 2019-02-07
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. 2019-01-31
BioStrata Ltd.. (1/29/19). "Press Release: BioStrata Announces New Hires to Drive Continued Growth across Its Specialist Marketing Communications Offering". Cambridge. 2019-01-29
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. 2019-01-28
Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. 2019-01-22
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. 2019-01-15
Immunocore Ltd.. (1/15/19). "Press Release: Immunocore Names David Berman as Head of R&D". Oxford & Conshohocken, PA. 2019-01-15
Deyton Bell Ltd.. (1/13/19). "Press Release: Deyton Bell Announce Exciting Further Expansion – Harriet Fear Joins the Team". 2019-01-13
Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. 2019-01-07
AstraZeneca plc. (1/7/19). "Press Release: AstraZeneca Announces Organisational Changes". 2019-01-07
Aptamer Group Ltd.. (1/7/19). "Press Release: Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices". 2019-01-07
Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". 2019-01-04
Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge. 2018-12-20
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Alnylam Pharmaceuticals, Inc.. (12/10/18). "Press Release: Alnylam Announces Settlement of Litigation with Silence Therapeutics". Cambridge, MA. 2018-12-10
AstraZeneca plc. (12/10/18). "Press Release: AstraZeneca and Cancer Research UK Launch Functional Genomics Centre to Accelerate the Discovery of New Medicines". 2018-12-10
AstraZeneca plc. (12/7/18). "Press Release: Update on the Phase III EAGLE Trial of Imfinzi and Tremelimumab in Advanced Head and Neck Cancer". 2018-12-07
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. 2018-11-29
Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen. 2018-11-29
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". 2018-11-27
Engitix Ltd.. (11/27/18). "Press Release: UCL Spin-out Engitix Closes £5m Financing to Progress Liver Disease and Pancreatic Cancer Drug Discovery Platform and Pipeline". London. 2018-11-27
Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London. 2018-11-26
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
Immune Regulation Ltd.. (11/26/18). "Press Release: Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104". Stevenage. 2018-11-26
Fluidic Analytics Ltd.. (11/26/18). "Press Release: Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases". 2018-11-26
GlaxoSmithKline plc. (11/26/18). "Press Release: Juluca (dolutegravir/rilpivirine), the First Single Pill, 2-drug Regimen, for the Maintenance Treatment of HIV, Granted Marketing Approval by Japan Ministry of Health, Labour and Welfare". London. 2018-11-26
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate Announces Change of Name to Immune Regulation, Strengthening of the Board and Successful Fundraise". 2018-11-22
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. 2018-11-21
Celyad S.A.. (11/21/18). "Press Release: Celyad Announces Third Quarter 2018 Business Update". Mont-Saint-Guibert. 2018-11-21
Goodwin Procter LLC. (11/15/18). "Press Release: Goodwin Adds Life Sciences and Technology Partner Sophie McGrath in London". London. 2018-11-15
Virion Biotherapeutics Ltd.. (11/14/18). "Press Release: Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections". London. 2018-11-14
Hox Therapeutics Ltd.. (11/13/18). "Press Release: Hox Therapeutics Appoints Karl Keegan as Chief Executive Officer". Guildford, Surrey. 2018-11-13
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London. 2018-11-12
Sygnature Discovery Ltd.. (11/8/18). "Press Release: Sygnature Discovery Announces Multi-target Drug Discovery Deal with Sitryx Therapeutics". 2018-11-08
AstraZeneca plc. (11/6/18). "Press Release: Divestment of Rights to Alvesco, Omnaris and Zetonna to Covis Pharma". 2018-11-06
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option". Boston, MA & London. 2018-11-05
DefiniGen Ltd.. (10/30/18). "Press Release: DefiniGen Licenses Broad Institute CRISPR-Cas9 Gene Editing Technology for Optimized Metabolic Disease Drug Development". Cambridge. 2018-10-30
Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. 2018-10-30
Immunocore Ltd.. (10/26/18). "Press Release: Immunocore CEO Andrew Hotchkiss Appointed to the Board of the BIA". Oxford & Conshohocken, PA. 2018-10-26
MeiraGTx Holdings plc. (10/25/18). "Press Release: MeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial Officer". London & New York, NY. 2018-10-25
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
Innate Pharma S.A.. (10/23/18). "Press Release: Innate Pharma Strengthens and Expands Its Oncology Development Collaboration with AstraZeneca". Marseille. 2018-10-23
NodThera Ltd.. (10/23/18). "Press Release: NodThera Announces the Appointment of Alison Strutt PhD as Head of Finance & Operations, the Launch of Its New Corporate Office in Boston and the Opening of Its Laboratory in Seattle". Cambridge, Boston, MA & Se 2018-10-23
Medicines Discovery Catapult, The. (10/22/18). "Press Release: Overcoming Bottlenecks in Early Drug Discovery with the Power of Sound. Medicines Discovery Catapult and AstraZeneca Collaborate to Unlock the Potential of Acoustic Mist Ionisation Mass Spect 2018-10-22
Kiadis Pharma N.V.. (10/19/18). "Press Release: Kiadis Pharma Raises €31.2 Million in a Private Placement of 3.9 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam. 2018-10-19
Kiadis Pharma N.V.. (10/18/18). "Press Release: Kiadis Pharma Launches a Private placement of approximately 3.7 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam. 2018-10-18
Amgen Inc.. (10/18/18). "Press Release: Amgen Invests £50 Million ($66 Million) in Oxford Nanopore Technologies". Thousand Oaks, CA & Oxford. 2018-10-18
MeiraGTx Holdings plc. (10/16/18). "Press Release: MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology". London & New York, NY. 2018-10-16
Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. 2018-10-16
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
Owlstone Medical. (10/10/18). "Press Release: Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board". Cambridge. 2018-10-10
MeiraGTx Holdings plc. (10/9/18). "Press Release: MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease". London & New York. 2018-10-09
Hummingbird Diagnostics GmbH. (10/9/18). "Press Release: Jörg Debatin to Chair the Supervisory Board of Hummingbird Diagnostics GmbH". Heidelberg & Boston, MA. 2018-10-09
Sitryx Therapeutics Ltd.. (10/8/18). "Press Release: New Biopharmaceutical Company Sitryx Launches with $30 Million Fundraising to Develop Disease Modifying Therapeutics in Immunometabolism". Oxford. 2018-10-08
Bluebird Bio, Inc.. (10/5/18). "Press Release: Bluebird Bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia". Cambridge, MA. 2018-10-05
Celyad S.A.. (10/4/18). "Press Release: Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop NextGeneration Allogeneic CAR-T Therapies". Mont-Saint-Guibert. 2018-10-04
Owlstone Medical Ltd.. (10/1/18). "Press Release: Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round". Cambridge. 2018-10-01
Taros Chemicals GmbH & Co. KG. (10/1/18). "Press Release: Taros Appoints Torsten Hoffmann as Senior Vice President Drug Discovery". Dortmund. 2018-10-01
Arix Bioscience plc. (10/1/18). "Press Release: Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio". London. 2018-10-01
Evonetix Ltd.. (10/1/18). "Press Release: Evonetix Partner with LioniX International to Enable DNA Synthesis at Scale". Cambridge & Enschede. 2018-10-01
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
TTP Labtech Ltd.. (9/27/18). "Press Release: Battery Ventures Acquires TTP Labtech Limited, Global Leader in Liquid Handling & Sample Management Technologies". Cambridge. 2018-09-27
Nightstar Therapeutics plc. (9/27/18). "Press Release: Nightstar Announces Pricing of Public Offering". Waltham, MA & London. 2018-09-27
Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. 2018-09-26
Nightstar Therapeutics plc. (9/25/18). "Press Release: Nightstar Announces Proposed Public Offering of American Depositary Shares". Waltham, MA & London. 2018-09-25
NodThera Ltd.. (9/24/18). "Press Release: NodThera Announces the Appointment of Adam Keeney PhD as President and Chief Executive Officer". Cambridge & Boston, MA. 2018-09-24
Thermo Fisher Scientific Inc.. (9/24/18). "Press Release: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis". Cannes-Mandelieu. 2018-09-24
Domainex Ltd.. (9/20/18). "Press Release: Domainex Appoints Dr Trevor Perrior as Chief Executive Officer". Cambridge. 2018-09-20
Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G 2018-09-20
Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover 2018-09-19
Cancer Research UK. (9/17/18). "Press Release: London Biotherapeutics Powerhouse Launched by Cancer Research UK". 2018-09-17
BIA Separations d.o.o.. (9/17/18). "Press Release: BIA Separations Expands with New Upstream Processing Facility". Ajdovšcina. 2018-09-17
Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge. 2018-09-17
Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. 2018-09-17
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top